This invention provides compounds of Formula I having the structure
##STR1##
wherein R.sub.1, R.sub.2, R.sub.3, W, X, and Z are as defined hereinbefore
or a pharmaceutically acceptable salt thereof, which are useful in
treating metabolic disorders related to insulin resistance or
hyperglycemia.